MPG.eBooks - Search Results - "Coronary Artery Disease / Drug Therapy"

Cover Image

1

CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease

Published 2018

CADTH

Subjects: “...Coronary Artery Disease / drug therapy...”

Cover Image

2

Clinical review report: Rivaroxaban (Xarelto) Bayer Inc. : indication : in combination with 75 mg to 100 mg acetylsalicylic acid, for the prevention of stroke, myocardial infarctio...

Published 2019

CADTH

Subjects: “...Coronary Artery Disease / drug therapy...”

Cover Image

3

CADTH Canadian Drug Expert Committee recommendation: Rivaroxaban (Xarelto -- Bayer Inc.) : indication : coronary artery disease with or without peripheral artery disease

Published 2018

CADTH

Subjects: “...Coronary Artery Disease / drug therapy...”

Cover Image

4

Clinical review report: Rivaroxaban (Xarelto) Bayer Inc. : indication : in combination with 75 mg to 100 mg acetylsalicylic acid, for the prevention of stroke, myocardial infarctio...

Published 2019

CADTH

Subjects: “...Coronary Artery Disease / drug therapy...”

Cover Image

5

Ischemic heart disease : part 2 of 2

by Lal, Vivek
Published 2014

Henry Stewart Talks

Subjects: “...Coronary Artery Disease / drug therapy...”

Cover Image

6

Pharmacoeconomic review report: Rivaroxaban (Xarelto) (Bayer Inc.) : indication : in combination with 75 mg to 100 mg acetylsalicylic acid (ASA), for the prevention of stroke, myoc...

Published 2019

CADTH

Subjects: “...Coronary Artery Disease / drug therapy...”

Cover Image

7

Pharmacoeconomic review report: Rivaroxaban (Xarelto) (Bayer Inc.) : indication : in combination with 75 mg to 100 mg acetylsalicylic acid (ASA), for the prevention of stroke, myoc...

Published 2019

CADTH

Subjects: “...Coronary Artery Disease / drug therapy...”